"What is discussed at IMPAKT can directly lead to new ways of designing trials that would hopefully lead to new protocols in the course of the next few years and could change outcome for patients."
Andrew Tutt and Peter Dubsky, IMPAKT 2013 Co-Chairs
IMPAKT 2013 will build on topics discussed in previous years and will focus specifically on the following areas – Watch the video here[http://www.youtube.com/watch?v=X_anpC5WZPg]:
The full conference programme is available at http://www.esmo.org/events/breast-2013-impakt/program.html
The 2013 Press Programme will capture the very essence of the IMPAKT conference, where the ultimate goal is to improve breast cancer outcome through translational research, i.e. new techniques, new concepts on the cutting edge to change the clinic as soon as possible:
Thursday, 2 May 2013, 10:45-11:45 (CEST)
Hosts: Martine Piccart, Jules Bordet Institute, Head of Chemotherapy Unit, Brussels, Belgium, IMPAKT Co-Founder Peter Dubsky, Vienna General Hospital (AKH) - Medizinische Universität Wien, Vienna, Austria, IMPAKT2013 Scientific Chair Andrew Tutt, King's College London Guy's Hospital, London, United Kingdom, IMPAKT2013 Executive Chair
BIG and ESMO welcome media interested in obtaining information and reporting on cancer issues. Registration is free to bona fide journalists on presentation of a letter of assignment and a valid press card. Media representatives are required to observe and abide by the Media Policy < http://www.esmo.org/fileadmin/media/pdf/2013/events/IMPAKT-2013/ESMO-IMPAKT-2013-Media-Policy.pdf >. A press centre with facilities will be available to registered journalists (Lounge on the mezzanine).
Please contact the IMPAKT Press Office at email@example.com to request press releases, schedule remote interviews or register for the event. < http://www.formstack.com/forms/esmo-media_application__5th_impakt_breast_cancer_conference__brussels > Media registration in advance is strongly recommended although on-site registration will still be possible.
Abstracts accepted for poster presentation and for publication in the IMPAKT Abstract book will be made public online on Monday, 22 April 2013 and will be accessible at http://www.esmo.org/events/breast-2013-impakt/program.html
Abstracts accepted for oral presentation and abstracts selected for the official IMPAKT Press Programme will be embargoed until the official opening of the IMPAKT 2013 Conference, Thursday, 2 May 2013, 12:00 (CEST)
Journalists are required to observe embargoes as indicated, thank you!
Around 500 attendees are expected from throughout Europe and the rest of the world.
The IMPAKT Breast Cancer Conference is an initiative by the Breast International Group (BIG) and the European Society for Medical Oncology (ESMO), in collaboration with the St. Gallen Primary Therapy of Early Breast Cancer Conference, The European Organisation for Research and Treatment of Cancer Breast Cancer Group, The European Society of Breast Cancer Specialists, and Europa Donna – the European Breast Cancer Coalition.
For further information please contact:
IMPAKT Press Office
c/o European Society for Medical Oncology
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.